H.R. 3551 (102nd): To amend the Internal Revenue Code of 1986, to extend the credit for clinical testing expenses for certain drugs for rare diseases or conditions, to impose a windfall profit tax on such drugs if they become excessively profitable, and for other purposes.


Oct 10, 1991
102nd Congress, 1991–1992

Died in a previous Congress

This bill was introduced on October 10, 1991, in a previous session of Congress, but was not enacted.


Fortney “Pete” Stark

Representative for California's 9th congressional district


About the bill

Summary (CRS)

Amends the Internal Revenue Code to extend through 1993 the tax credit for clinical testing expenses for certain drugs for rare diseases or conditions.Includes preclinical testing expenses under such tax ... Read more >

The bill’s title was written by its sponsor.


Oct 10, 1991

This is the first step in the legislative process.

This is a House of Representatives bill in the United States Congress (indicated by the “H.R.” in “H.R. 3551”). A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.


Committee Assignments

The committee chair determines whether a bill will move past the committee stage.


There have been no roll call votes related to this bill.

Related Bills

Legislative action may be ocurring on one of these bills in lieu of or in parallel to action on this bill.

H.R. 5421 (101st) was a previous version of this bill.

Referred to Committee
Last Action: Jul 31, 1990

H.R. 1713 (identical)

Referred to Committee
Last Action: Apr 10, 1991

Search for similar bills.

Links & tools

Primary Source

THOMAS.gov (The Library of Congress)

GovTrack gets most information from THOMAS, which is updated generally one day after events occur. Activity since the last update may not be reflected here. Data comes via the congress project.


Click a format for a citation suggestion: